Illumina, Inc. vs New York Times Co — how do they compare? Illumina, Inc. trades at $192.8 (market cap $27.94B), while New York Times Co trades at $75.56 (market cap $12.29B). The key difference: Illumina, Inc. is far larger — about 2.3× New York Times Co's market cap, and New York Times Co pays a 1.21% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals.
| ILMN | NYT | |
|---|---|---|
Market Cap | $27.94B | $12.29B |
Sector | Health | Media |
52-Week High | $194.33 | $85.86 |
52-Week Low | $91.00 | $51.43 |
Enterprise Value | $29.33B | $11.68B |
Dividend Yield | — | 1.21% |
Trailing returns across standard periods
Latest headlines on both assets
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →New York Times Co is an American media company known for publishing its flagship newspaper, The New York Times. The company also operates the International New York Times newspaper, as well as digital properties such as nytimes and various smartphone applications. Circulation of The New York Times is the source of revenue for the company, followed by print and digital advertising and its paid digital-only subscription to The New York Times. The company has a daily print circulation of over 500,000 and 1,000,000 on Sundays. The source of growth for The New York Times is its digital subscription service, which has over 1,000,000 paid users.
Read more on NYT →